O 607 | 336104-73-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: O 607
• 英文别名: 6-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-3-yl]-6-methylheptanoic acid
• CAS: 336104-73-5
• 化学式: C₂₄H₃₄O₄
• 分子量: 386.532
• InChiKey: SBRCSLDTRJWUST-QZTJIDSGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  O 607 生成 O-2352
  参考文献：
  名称：

  [EN] WATER-SOLUBLE CANNABINOIDS
  [FR] CANNABINOIDES SOLUBLES DANS L'EAU

  摘要：

  提供了一种可以溶于水的作用于CB1和CB2大麻素受体的大麻素类化合物。通过对四氢大麻酚的烷基侧链和/或酚羟基进行衍生化，使这些化合物可以溶于水。这些水溶性大麻素化合物可用于治疗食欲不振、疼痛、多发性硬化症、恶心和呕吐以及癫痫等疾病。

  公开号：

  WO2006012176A1
• 作为产物：
  描述：

  3,5-二甲氧基苯腈 在 盐酸 、 氢氧化钾 、 三溴化硼 、 四氯化钛 、 对甲苯磺酸 作用下， 以 乙醇 、 二氯甲烷 、 二甲基亚砜 、 苯 为溶剂， 反应 34.17h， 生成 O 607
  参考文献：
  名称：

  Potent Cyano and Carboxamido Side-Chain Analogues of 1‘,1‘-Dimethyl-Δ⁸-Tetrahydrocannabinol

  摘要：

  The synthesis and pharmacological profile of several cyano (1a-e) and carboxamido (2a-h) side-chain-substituted analogues of 1',1'-dimethyl-Delta(8)-THC are described. Commercially available cyano compound 3 was transformed to the resorcinol 6 in a three-step sequence. Condensation of 6 with p-menth-2-ene-1,8-diol formed the THC 7a which, with sodium cyanide/ DMSO, gave Ib. Protection of the phenol in 7a as the MOM derivative provided the common intermediate 8 for the synthesis of 1a,c,e. Compound 1d was also synthesized from 7a via the aldehyde 9a. Base hydrolysis of 1b gave the acid 10 which, via its acid chloride and subsequent treatment with the appropriate amine, formed the target compounds 2a-h. The pharmacological profile indicated that the cyano analogues 1a-e had very high CB1 binding affinity (0.36-13 nM) and high in vivo potency as agonists. Two analogues (1a,b) had extremely high potency in the mouse tetrad tests. The dimethylcarboxamido analogue 2a showed a similar profile to 1a,b. The high potency was also retained in analogue 2c. In contrast the sulfonamide analogue 2d was unique as it had greater affinity than Delta(9)-THC, yet it was practically devoid of agonist effects. This study suggests that the incorporation of a cyano or an amide substituent in the side chain of Delta(8)-THC-DMH can enhance potency and can also lead to compounds with a unique profile which have high binding affinity and are practically devoid of agonist effects.

  DOI：

  10.1021/jm9803875

文献信息

• METHODS AND COMPOSITIONS RELATING TO ULTRAPURE 5-(1,1-DIMETHYLHEPTYL)-RESORCINOL
  申请人：Corbus Pharmaceuticals, Inc.

  公开号：US20210198223A1

  公开（公告）日：2021-07-01

  The invention provides methods and compositions relating to an ultrapure formulation of 5-(1,1-dimethylheptyl)-resorcinol (ultrapure DMHR). The invention features methods for making ultrapure DMHR, including methods that minimize the production of unwanted side products (e.g., the production of homologous alkyl-chain impurities). The invention also features methods of making cannabinoids, such as (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carboxylic acid (ajulemic acid), using ultrapure DMHR, including methods that minimize the production of unwanted side products (e.g., the production of homologous alkyl-chain impurities) in the resulting cannabinoid preparation.
• Potent Cyano and Carboxamido Side-Chain Analogues of 1‘,1‘-Dimethyl-Δ⁸-Tetrahydrocannabinol
  作者：Michael Singer、William J. Ryan、Bijali Saha、Billy R. Martin、Raj K. Razdan

  DOI：10.1021/jm9803875

  日期：1998.10.1

  The synthesis and pharmacological profile of several cyano (1a-e) and carboxamido (2a-h) side-chain-substituted analogues of 1',1'-dimethyl-Delta(8)-THC are described. Commercially available cyano compound 3 was transformed to the resorcinol 6 in a three-step sequence. Condensation of 6 with p-menth-2-ene-1,8-diol formed the THC 7a which, with sodium cyanide/ DMSO, gave Ib. Protection of the phenol in 7a as the MOM derivative provided the common intermediate 8 for the synthesis of 1a,c,e. Compound 1d was also synthesized from 7a via the aldehyde 9a. Base hydrolysis of 1b gave the acid 10 which, via its acid chloride and subsequent treatment with the appropriate amine, formed the target compounds 2a-h. The pharmacological profile indicated that the cyano analogues 1a-e had very high CB1 binding affinity (0.36-13 nM) and high in vivo potency as agonists. Two analogues (1a,b) had extremely high potency in the mouse tetrad tests. The dimethylcarboxamido analogue 2a showed a similar profile to 1a,b. The high potency was also retained in analogue 2c. In contrast the sulfonamide analogue 2d was unique as it had greater affinity than Delta(9)-THC, yet it was practically devoid of agonist effects. This study suggests that the incorporation of a cyano or an amide substituent in the side chain of Delta(8)-THC-DMH can enhance potency and can also lead to compounds with a unique profile which have high binding affinity and are practically devoid of agonist effects.
• [EN] WATER-SOLUBLE CANNABINOIDS<br/>[FR] CANNABINOIDES SOLUBLES DANS L'EAU
  申请人：UNIV VIRGINIA COMMONWEALTH

  公开号：WO2006012176A1

  公开（公告）日：2006-02-02

  Water-soluble cannabinoid compounds that are agonists of CB1 and CB2 cannabinoid receptors are provided. The compounds are made water-soluble by derivatization of the alkyl side chain and/or the phenolic hydroxyl group of tetrahydrocannabinol. The water-soluble cannabinoids are useful for the treatment of appetite loss, pain, multiple sclerosis, nausea and vomiting, and epilepsy.

  提供了一种可以溶于水的作用于CB1和CB2大麻素受体的大麻素类化合物。通过对四氢大麻酚的烷基侧链和/或酚羟基进行衍生化，使这些化合物可以溶于水。这些水溶性大麻素化合物可用于治疗食欲不振、疼痛、多发性硬化症、恶心和呕吐以及癫痫等疾病。